NeoGenomics
NEO
64 hedge funds and large institutions have $82.9M invested in NeoGenomics in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 10 reducing their positions, and 9 closing their positions.
140% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 10
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
50% more capital invested
Capital invested by funds: $55.2M → $82.9M (+$27.7M)
10% more funds holding
Funds holding: 58 → 64 (+6)
8% more call options, than puts
Call options by funds: $13K | Put options by funds: $12K
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.67M |
| 2 |
CM
Castleark Management
Chicago,
Illinois
|
-$2.98M |
| 3 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
-$2.04M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$138K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$113K |
NEO Hedge Fund Activity: Q4 2013 in Review
64 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q4 2013, worth a combined $82.9M — up 50% from $55.2M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new NEO positions and 9 closed out — a net gain of 6 holders — while 24 added to existing stakes and 10 trimmed.
The largest buyer was Granahan Investment Management, adding an estimated $2.23M. The largest seller was Wellington Management Group, cutting an estimated $6.67M.
- 64 institutional investors held NeoGenomics (NEO) as of Q4 2013, up from 58 in Q3 2013.
- Funds reported $82.9M of NeoGenomics stock for Q4 2013, up 50% quarter-over-quarter.
- 15 funds opened new NeoGenomics positions in Q4 2013 and 9 closed out, a net change of +6 holders.
- The largest NeoGenomics buyer in Q4 2013 was Granahan Investment Management, an estimated $2.23M added.
- The largest NeoGenomics seller in Q4 2013 was Wellington Management Group, an estimated $6.67M sold.
Based on aggregated 13F filings for Q4 2013.